Source: Virtual Congress 2021 – Adult cystic fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
D. Westhölter (Essen, Germany), H. Beckert (Essen, Germany), S. Strassburg (Essen, Germany), M. Welsner (Essen, Germany), S. Sutharsan (Essen, Germany), C. Taube (Essen, Germany), S. Reuter (Essen, Germany). Chronic Pseudomonas aeruginosa lung infection, but not CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis. 1499

Member's Comments

No comment yet.

Related content which might interest you: Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells Source: Eur Respir J 2015; 45: 1590-1602 Year: 2015 Role of regulatory T cells in S. pneumoniae-induced exacerbation of lung fibrosis in mice Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Association of IL-8 A-251T polymorphism with Pseudomonas aeruginosa infection and lung function decline in children with CF Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Impact of Pseudomonas aeruginosa infection on Na+ transport in airway epithelia Source: Annual Congress 2007 - The impact of viral and bacterial infection on the respiratory epithelium Year: 2007 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Dysregulation of systemic and local immune response in cystic fibrosis patients with chronic P. aeruginosa infection Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016 Year: 2017 Role of regulatory T-cells (Tregs) in bacterial infection-induced lung fibrosis exacerbation in mice Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Single nucleotide polymorphisms in genes of the innate immunity in cystic fibrosis patients: correlation with lung function and pseudomonas aeruginosa (P.a.) colonisation Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Cytokine and chemokine release in response to Pseudomonas aeruginosa (PA), by bronchial epithelium of the native airway and transplanted lung of paediatric cystic fibrosis (CF) lung transplant recipients Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections Source: Eur Respir J 2012; 40: 227-238 Year: 2012 The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021 Year: 2021 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008